Justin Spencer Insider Profile
4 Followers
Justin Spencer, Director at Health Catalyst, holds 149.26K shares in Health Catalyst (Ticker: HCAT), holds 124.40K shares in Vocera (Ticker: VCRA), holds 0.00 shares in iPass (Ticker: IPAS).
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+23.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Justin Spencer holds in companies
Most Profitable Insider Trade
Stock:
Vocera
(VCRA)
(VCRA)
Rating:Informative Buy
Date:Nov 18, 2014 - Nov 18, 2015
Return:+29.20%
The most profitable trade made by Justin Spencer
Justin Spencer's Trading History
Health Catalyst
Jul 20, 2026
Director
Uninformative Buy
―
$271.66K
iPass
Feb 21, 2019
―
Uninformative Sell
―
$0.00
Vocera
Jun 15, 2021
―
Uninformative Sell
220.32K
$9.84M
Symmetricom
―
―
―
―
List of latest transactions for each holding click on a transaction to see Justin Spencer's performance on stock
You May Also Like
Justin Spencer insider profile FAQ
What is the percentage of profitable transactions made by Justin Spencer?
The percentage of profitable transactions made by Justin Spencer is 100%.
What is the average return per transaction made by Justin Spencer?
The average return per transaction made by Justin Spencer is 23.80%.
What stocks does Justin Spencer hold?
Justin Spencer holds: HCAT, IPAS, VCRA, SYMM stocks.
What was Justin Spencer’s latest transaction?
Justin Spencer latest transaction was an Uninformative Buy of ―.
What was Justin Spencer's most profitable transaction?
Justin Spencer’s most profitable transaction was an Informative Buy of VCRA stock on November 18, 2014. The return on the trade was 29.20%.
What is Justin Spencer's role in Health Catalyst?
Justin Spencer's role in Health Catalyst is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.